The invention relates to benzimidazole acetic acid compounds which function as antagonists of the Chemoattractant Receptor-homologous molecule expressed on T-Helper type 2 cells (CRTH2) receptor. The invention also relates to the use of these compounds to inhibit the binding of prostaglandin D
2
and its metabolites or certain thromboxane metabolites to the CRTH2 receptor and to treat disorders responsive to such inhibition.
本发明涉及
苯并咪唑乙酸化合物,其作为
趋化因子受体同源分子在T-Helper 2细胞上的拮抗剂(CRTH2)受体。本发明还涉及使用这些化合物来抑制
前列腺素D2及其代谢物或某些血栓素代谢物与CRTH2受体的结合,并用于治疗对此类抑制有反应的疾病。